Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research interests include Mosquito-borne diseases and control, SARS-CoV-2 and COVID-19 Research, Viral Infections and Vectors, and COVID-19 Clinical Research Studies.
Muco‐Penetrating Lipid Nanoparticles Having a Liquid Core for Enhanced Intranasal mRNA Delivery
The seven enigmas of SARS-CoV-2: From the past to the future
Deleterious variants in the autophagy-related gene RB1CC1/FIP200 impair immunity to SARS-CoV-2
Design and Characterization of a New Formulation for the Delivery of COVID-19-mRNA Vaccine to the Nasal Mucosa
SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency
Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during chikungunya
A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity
Heterozygous <i>BTNL8</i> variants in individuals with multisystem inflammatory syndrome in children (MIS-C)
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection
Author Correction: Chikungunya fever
Positive‐strand RNA viruses—a Keystone Symposia report
Monkeypox: disease epidemiology, host immunity and clinical interventions
Human genetic and immunological determinants of critical COVID-19 pneumonia
Studying severe long COVID to understand post-infectious disorders beyond COVID-19
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation
Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients
COVID-19 vaccines and kidney disease
Epitope-Functionalized Gold Nanoparticles for Rapid and Selective Detection of SARS-CoV-2 IgG Antibodies
Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells
Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19